Adrian Rawcliffe

Adaptimmune Therapeutics PLC (ADAP)
     GBR
Total Compensation for Fiscal Year Ending in 2022: $3,408,527
Salary $650,000
Bonus $0
Value of Stock Awards $0
Value of Option Awards $2,714,882
Non-Equity Incentive Plan Compensation $0
Change in Pension Value and Deferred Compensation Earnings $0
All Other Compensation $43,645
Total $3,408,527
Adaptimmune Therapeutics PLC disclosed its CEO pay was
27
times its median employee's pay for the fiscal year ending in 2022.
How Do You Compare?